These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36297546)

  • 1. Lactoferrin Binding to SARS-CoV-2 Spike Glycoprotein Blocks Pseudoviral Entry and Relieves Iron Protein Dysregulation in Several In Vitro Models.
    Cutone A; Rosa L; Bonaccorsi di Patti MC; Iacovelli F; Conte MP; Ianiro G; Romeo A; Campione E; Bianchi L; Valenti P; Falconi M; Musci G
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mimicry of the receptor-binding domain of the SARS-CoV-2 spike protein: from the interaction of spike-specific antibodies with transferrin and lactoferrin to the antiviral effects of human recombinant lactoferrin.
    Sokolov AV; Isakova-Sivak IN; Mezhenskaya DA; Kostevich VA; Gorbunov NP; Elizarova AY; Matyushenko VA; Berson YM; Grudinina NA; Kolmakov NN; Zabrodskaya YA; Komlev AS; Semak IV; Budevich AI; Rudenko LG; Vasilyev VB
    Biometals; 2023 Jun; 36(3):437-462. PubMed ID: 36334191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactoferrin Against SARS-CoV-2:
    Campione E; Lanna C; Cosio T; Rosa L; Conte MP; Iacovelli F; Romeo A; Falconi M; Del Vecchio C; Franchin E; Lia MS; Minieri M; Chiaramonte C; Ciotti M; Nuccetelli M; Terrinoni A; Iannuzzi I; Coppeda L; Magrini A; Bernardini S; Sabatini S; Rosapepe F; Bartoletti PL; Moricca N; Di Lorenzo A; Andreoni M; Sarmati L; Miani A; Piscitelli P; Valenti P; Bianchi L
    Front Pharmacol; 2021; 12():666600. PubMed ID: 34220505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection.
    Rosa L; Cutone A; Conte MP; Campione E; Bianchi L; Valenti P
    Biometals; 2023 Jun; 36(3):417-436. PubMed ID: 35920949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation.
    Beirag N; Kumar C; Madan T; Shamji MH; Bulla R; Mitchell D; Murugaiah V; Neto MM; Temperton N; Idicula-Thomas S; Varghese PM; Kishore U
    Front Immunol; 2022; 13():960733. PubMed ID: 35967323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Influence of Viral Infections on Iron Homeostasis and the Potential for Lactoferrin as a Therapeutic in the Age of the SARS-CoV-2 Pandemic.
    Ward JL; Torres-Gonzalez M; Ammons MCB
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactoferrin Efficiently Counteracts the Inflammation-Induced Changes of the Iron Homeostasis System in Macrophages.
    Cutone A; Rosa L; Lepanto MS; Scotti MJ; Berlutti F; Bonaccorsi di Patti MC; Musci G; Valenti P
    Front Immunol; 2017; 8():705. PubMed ID: 28663751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin.
    Miotto M; Di Rienzo L; Bò L; Boffi A; Ruocco G; Milanetti E
    Front Mol Biosci; 2021; 8():607443. PubMed ID: 33659275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction.
    Balkrishna A; Haldar S; Singh H; Roy P; Varshney A
    J Inflamm Res; 2021; 14():869-884. PubMed ID: 33758527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of
    Iacovelli F; Costanza G; Romeo A; Cosio T; Lanna C; Bagnulo A; Di Maio U; Sbardella A; Gaziano R; Grelli S; Squillaci E; Miani A; Piscitelli P; Bianchi L; Falconi M; Campione E
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbo-mineral formulation, Divya-Swasari-Vati averts SARS-CoV-2 pseudovirus entry into human alveolar epithelial cells by interfering with spike protein-ACE 2 interaction and IL-6/TNF-α /NF-κB signaling.
    Balkrishna A; Goswami S; Singh H; Gohel V; Dev R; Haldar S; Varshney A
    Front Pharmacol; 2022; 13():1024830. PubMed ID: 36386162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an
    Pandey P; Rane JS; Chatterjee A; Kumar A; Khan R; Prakash A; Ray S
    J Biomol Struct Dyn; 2021 Oct; 39(16):6306-6316. PubMed ID: 32698689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.
    Rahman M; Irmler M; Keshavan S; Introna M; Beckers J; Palmberg L; Johanson G; Ganguly K; Upadhyay S
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents.
    Nandi S; Roy H; Gummadi A; Saxena AK
    Curr Drug Targets; 2021; 22(17):2006-2020. PubMed ID: 33687893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    Lavie M; Dubuisson J; Belouzard S
    J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate-binding protein from stinging nettle as fusion inhibitor for SARS-CoV-2 variants of concern.
    Vanhulle E; D'huys T; Provinciael B; Stroobants J; Camps A; Noppen S; Schols D; Van Damme EJM; Maes P; Stevaert A; Vermeire K
    Front Cell Infect Microbiol; 2022; 12():989534. PubMed ID: 36111239
    [No Abstract]   [Full Text] [Related]  

  • 17. The interactions of ZDHHC5/GOLGA7 with SARS-CoV-2 spike (S) protein and their effects on S protein's subcellular localization, palmitoylation and pseudovirus entry.
    Zeng XT; Yu XX; Cheng W
    Virol J; 2021 Dec; 18(1):257. PubMed ID: 34961524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study.
    Rosa L; Tripepi G; Naldi E; Aimati M; Santangeli S; Venditto F; Caldarelli M; Valenti P
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
    Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
    Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
    Zhu Y; Yu D; Yan H; Chong H; He Y
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.